Annual CFF
$116.41 M
+$116.38 M+363675.00%
December 31, 2023
Summary
- As of February 7, 2025, IMNM annual cash flow from financing activities is $116.41 million, with the most recent change of +$116.38 million (+363675.00%) on December 31, 2023.
- During the last 3 years, IMNM annual CFF has risen by +$66.47 million (+133.08%).
- IMNM annual CFF is now at all-time high.
Performance
IMNM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$305.00 K
-$389.00 K-56.05%
September 30, 2024
Summary
- As of February 7, 2025, IMNM quarterly cash flow from financing activities is $305.00 thousand, with the most recent change of -$389.00 thousand (-56.05%) on September 30, 2024.
- Over the past year, IMNM quarterly CFF has dropped by -$55.19 million (-99.45%).
- IMNM quarterly CFF is now -99.86% below its all-time high of $219.44 million, reached on March 31, 2024.
Performance
IMNM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$275.94 M
-$60.57 M-18.00%
September 30, 2024
Summary
- As of February 7, 2025, IMNM TTM cash flow from financing activities is $275.94 million, with the most recent change of -$60.57 million (-18.00%) on September 30, 2024.
- Over the past year, IMNM TTM CFF has increased by +$159.53 million (+137.05%).
- IMNM TTM CFF is now -18.00% below its all-time high of $336.51 million, reached on June 30, 2024.
Performance
IMNM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IMNM Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | -99.5% | +137.1% |
| 3 y3 years | +133.1% | +100.0% | +10000.0% |
| 5 y5 years | +10000.0% | +100.0% | +10000.0% |
IMNM Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -99.9% | +256.4% | -18.0% | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -99.9% | +177.6% | -18.0% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -99.9% | +177.6% | -18.0% | >+9999.0% |
Immunome Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $305.00 K(-56.1%) | $275.94 M(-18.0%) |
| Jun 2024 | - | $694.00 K(-99.7%) | $336.51 M(+0.2%) |
| Mar 2024 | - | $219.44 M(+295.4%) | $335.82 M(+188.5%) |
| Dec 2023 | $116.41 M(>+9900.0%) | $55.50 M(-8.8%) | $116.41 M(+91.1%) |
| Sep 2023 | - | $60.88 M(>+9900.0%) | $60.91 M(>+9900.0%) |
| Jun 2023 | - | $0.00(-100.0%) | $34.00 K(0.0%) |
| Mar 2023 | - | $34.00 K(>+9900.0%) | $34.00 K(+6.3%) |
| Dec 2022 | $32.00 K | $0.00(0.0%) | $32.00 K(-119.6%) |
| Sep 2022 | - | $0.00(0.0%) | -$163.00 K(-138.6%) |
| Jun 2022 | - | $0.00(-100.0%) | $422.00 K(-98.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $32.00 K(-116.4%) | $27.72 M(-0.2%) |
| Dec 2021 | $27.77 M(-44.4%) | -$195.00 K(-133.3%) | $27.77 M(-58.6%) |
| Sep 2021 | - | $585.00 K(-97.9%) | $67.09 M(+1.5%) |
| Jun 2021 | - | $27.30 M(>+9900.0%) | $66.11 M(+34.4%) |
| Mar 2021 | - | $76.00 K(-99.8%) | $49.17 M(-1.5%) |
| Dec 2020 | $49.94 M(+363.6%) | $39.13 M(<-9900.0%) | $49.94 M(+361.9%) |
| Sep 2020 | - | -$393.00 K(-103.8%) | $10.81 M(-3.5%) |
| Jun 2020 | - | $10.36 M(+1127.7%) | $11.21 M(+1227.7%) |
| Mar 2020 | - | $844.00 K | $844.00 K |
| Dec 2019 | $10.77 M(-2055.4%) | - | - |
| Dec 2018 | -$551.00 K | - | - |
FAQ
- What is Immunome annual cash flow from financing activities?
- What is the all time high annual CFF for Immunome?
- What is Immunome annual CFF year-on-year change?
- What is Immunome quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Immunome?
- What is Immunome quarterly CFF year-on-year change?
- What is Immunome TTM cash flow from financing activities?
- What is the all time high TTM CFF for Immunome?
- What is Immunome TTM CFF year-on-year change?
What is Immunome annual cash flow from financing activities?
The current annual CFF of IMNM is $116.41 M
What is the all time high annual CFF for Immunome?
Immunome all-time high annual cash flow from financing activities is $116.41 M
What is Immunome annual CFF year-on-year change?
Over the past year, IMNM annual cash flow from financing activities has changed by +$116.38 M (+363675.00%)
What is Immunome quarterly cash flow from financing activities?
The current quarterly CFF of IMNM is $305.00 K
What is the all time high quarterly CFF for Immunome?
Immunome all-time high quarterly cash flow from financing activities is $219.44 M
What is Immunome quarterly CFF year-on-year change?
Over the past year, IMNM quarterly cash flow from financing activities has changed by -$55.19 M (-99.45%)
What is Immunome TTM cash flow from financing activities?
The current TTM CFF of IMNM is $275.94 M
What is the all time high TTM CFF for Immunome?
Immunome all-time high TTM cash flow from financing activities is $336.51 M
What is Immunome TTM CFF year-on-year change?
Over the past year, IMNM TTM cash flow from financing activities has changed by +$159.53 M (+137.05%)